{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:03:30Z","timestamp":1789466610783,"version":"build-2803163510"},"reference-count":40,"publisher":"Tsinghua University Press","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lymphatic dysfunction plays a critical role in the development of atherosclerotic plaques, and targeting lymphatic regulation offers promising strategies for preventing and treating atherosclerosis (AS). This study aims to identify key genes influencing AS in lymphatic endothelial cells (LECs) followed by validation, and to explore potential intervention targets for AS treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single-cell data from the GEO database and Mendelian randomization was employed to identify genes in LECs that may either exacerbate or protect against AS. AS mouse models were established, followed by the assessment of key gene expression in lymphatic vessels within the plaque adventitia. In vitro, LECs were manipulated by silencing or overexpressing key genes to investigate the signaling pathways and mechanisms through which genes influence lymphangiogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Human carotid plaque data via the GEO database revealed that LEC-specific genes are closely associated with vasculogenesis, cell migration, and inflammatory responses during AS. Mendelian randomization analysis identified CD74 as a promoter of AS progression. In vivo experiments revealed a significant upregulation of CD74 expression during AS. Correlation analysis of CD74 in LECs with inflammatory genes from the GEO database, along with the in vitro construction of CD74 silencing and overexpression models in LECs, revealed the critical role of CD74 in the inflammatory response in AS. Gene correlation analysis and experimental validation revealed that CD74 promotes LEC pyroptosis through the NLRP3\/SYK pathway. Additionally, in vitro results demonstrated that CD74 impairs lymphangiogenesis by inducing pyroptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study has identified the key gene CD74 in LECs that influence the progression of AS. Moreover, during AS, CD74 mediates NLRP3\/SYK-dependent LEC pyroptosis, thereby inhibiting lymphangiogenesis and exacerbating the inflammatory response. These findings provide a novel molecular mechanism by which CD74 disrupts lymphatic function and accelerates AS progression, offering potential avenues for intervention in AS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.26599\/1671-5411.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:36:32Z","timestamp":1789461392000},"page":"456-473","source":"Crossref","is-referenced-by-count":0,"title":["Integrated analyses of single-cell transcriptome and mendelian randomization reveal the role of lymphatic endothelial CD74 in the progression of atherosclerosis"],"prefix":"10.26599","volume":"23","author":[{"given":"Heng-Xuan","family":"CAI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Peng","family":"MA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"JIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Yi","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gege","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Zhe","family":"LU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Ming","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shuo","family":"XU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Qian","family":"WENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Jie","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Ying","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"YU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hong","family":"FANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"ref1","first-page":"e38","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"M Writing Group","year":"2016","unstructured":"M Writing Group. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. 2016, 133: e38-360.","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2019.09.012","article-title":"Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review","volume":"293","author":"G Agnelli","year":"2020","unstructured":"G Agnelli. Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review. 2020, 293: 94-100.","journal-title":"Atherosclerosis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"P Libby","year":"2021","unstructured":"P Libby. The changing landscape of atherosclerosis. 2021, 592: 524-533.","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/ehjqcco\/qcaa076","article-title":"Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017","volume":"8","author":"H Dai","year":"2022","unstructured":"H Dai. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017. 2022, 8: 50-60.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/CIRCULATIONAHA.120.045851","article-title":"The expected 30-year benefits of early versus delayed primary prevention of cardiovascular disease by lipid lowering","volume":"142","author":"MJ Pencina","year":"2020","unstructured":"MJ Pencina. The expected 30-year benefits of early versus delayed primary prevention of cardiovascular disease by lipid lowering. 2020, 142: 827-837.","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"FLJ Visseren. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. 2021, 42: 3227-3337.","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"P Kong","year":"2022","unstructured":"P Kong. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. 2022, 7: 131.","journal-title":"Signal Transduct Target Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI182939","author":"","unstructured":"","journal-title":"null"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.122.061516","article-title":"Peptide vaccine against ADAMTS-7 ameliorates atherosclerosis and postinjury neointima hyperplasia","volume":"147","author":"Z Ma","year":"2023","unstructured":"Z Ma. Peptide vaccine against ADAMTS-7 ameliorates atherosclerosis and postinjury neointima hyperplasia. 2023, 147: 728-742.","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1172\/JCI63685","article-title":"Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice","volume":"123","author":"C Martel","year":"2013","unstructured":"C Martel. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. 2013, 123: 1571-1579.","journal-title":"J Clin Invest"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41569-021-00505-8","article-title":"Reduced lymphatic drainage promotes HFpEF and atherosclerosis","volume":"18","author":"GB Lim","year":"2021","unstructured":"GB Lim. Reduced lymphatic drainage promotes HFpEF and atherosclerosis. 2021, 18: 149.","journal-title":"Nat Rev Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e006892","DOI":"10.1161\/JAHA.117.006892","article-title":"Apolipoprotein A-I modulates atherosclerosis through lymphatic vessel-dependent mechanisms in mice","volume":"6","author":"A Milasan","year":"2017","unstructured":"A Milasan. Apolipoprotein A-I modulates atherosclerosis through lymphatic vessel-dependent mechanisms in mice. 2017, 6: e006892.","journal-title":"J Am Heart Assoc"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"27862","DOI":"10.1038\/srep27862","article-title":"Effects of LDL Receptor Modulation on Lymphatic Function","volume":"6","author":"A Milasan","year":"2016","unstructured":"A Milasan. Effects of LDL Receptor Modulation on Lymphatic Function. 2016, 6: 27862.","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/ATVBAHA.122.318904","article-title":"CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis","volume":"43","author":"B Singla","year":"2023","unstructured":"B Singla. CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis. 2023, 43: 1234-1250.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1096\/fj.201500112","article-title":"Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: a regulatory role for soluble VEGF receptor 2","volume":"30","author":"M Taher","year":"2016","unstructured":"M Taher. Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: a regulatory role for soluble VEGF receptor 2. 2016, 30: 2490-2499.","journal-title":"FASEB J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1093\/cvr\/cvab279","article-title":"Lymphatic contractile function: a comprehensive review of drug effects and potential clinical application","volume":"118","author":"PS Russell","year":"2022","unstructured":"PS Russell. Lymphatic contractile function: a comprehensive review of drug effects and potential clinical application. 2022, 118: 2437-2457.","journal-title":"Cardiovasc Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"167238","DOI":"10.1016\/j.bbadis.2024.167238","article-title":"A potential early-atheroprotective target: Irgm1 mediates lymphangiogenesis through LEC autophagy by Tfeb translocation","volume":"1870","author":"H Cai","year":"2024","unstructured":"H Cai. A potential early-atheroprotective target: Irgm1 mediates lymphangiogenesis through LEC autophagy by Tfeb translocation. 2024, 1870: 167238.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"12225","DOI":"10.18632\/aging.206057","article-title":"Melatonin downregulates angiogenesis and lymphangiogenesis by regulating tumor-associated macrophages via NLRP3 inflammasomes in lung adenocarcinoma","volume":"16","author":"Z Zhao","year":"2024","unstructured":"Z Zhao. Melatonin downregulates angiogenesis and lymphangiogenesis by regulating tumor-associated macrophages via NLRP3 inflammasomes in lung adenocarcinoma. 2024, 16: 12225-12238.","journal-title":"Aging (Albany NY)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.7150\/ijbs.66781","article-title":"CD137L-macrophage induce lymphatic endothelial cells autophagy to promote lymphangiogenesis in renal fibrosis","volume":"18","author":"H Wei","year":"2022","unstructured":"H Wei. CD137L-macrophage induce lymphatic endothelial cells autophagy to promote lymphangiogenesis in renal fibrosis. 2022, 18: 1171-1187.","journal-title":"Int J Biol Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e007402","DOI":"10.1136\/jitc-2023-007402","article-title":"Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment","volume":"11","author":"W Lin","year":"2023","unstructured":"W Lin. Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment. 2023, 11: e007402.","journal-title":"J Immunother Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.4049\/jimmunol.2200216","article-title":"TGF-\u03b2 signaling prevents MHC Class II-expressing lymphatic endothelial cells from reactivating human allogenic memory CD4+ T Cells","volume":"211","author":"R Mezyk-Kopec","year":"2023","unstructured":"R Mezyk-Kopec. TGF-\u03b2 signaling prevents MHC Class II-expressing lymphatic endothelial cells from reactivating human allogenic memory CD4+ T Cells. 2023, 211: 782-790.","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"11976","DOI":"10.3390\/ijms222111976","article-title":"Single-cell RNA sequencing reveals heterogeneity and functional diversity of lymphatic endothelial cells","volume":"22","author":"H den Braanker","year":"2021","unstructured":"H den Braanker. Single-cell RNA sequencing reveals heterogeneity and functional diversity of lymphatic endothelial cells. 2021, 22: 11976.","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/CIRCRESAHA.115.306544","article-title":"Lymphatic System in Cardiovascular Medicine","volume":"118","author":"A Aspelund","year":"2016","unstructured":"A Aspelund. Lymphatic System in Cardiovascular Medicine. 2016, 118: 515-530.","journal-title":"Circ Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2362.2010.02431.x","article-title":"Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol-rich and calcified atherosclerotic lesions","volume":"41","author":"I Kholova","year":"2011","unstructured":"I Kholova. Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol-rich and calcified atherosclerotic lesions. 2011, 41: 487-497.","journal-title":"Eur J Clin Invest"},{"key":"ref25","first-page":"26","article-title":"Adventitial lymphatics and atherosclerosis","volume":"45","author":"K Drozdz","year":"2012","unstructured":"K Drozdz. Adventitial lymphatics and atherosclerosis. 2012, 45: 26-33.","journal-title":"Lymphology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/jcm8071000","article-title":"Increased lymphangiogenesis and lymphangiogenic growth factor expression in perivascular adipose tissue of patients with coronary artery disease","volume":"8","author":"I Drosos","year":"2019","unstructured":"I Drosos. Increased lymphangiogenesis and lymphangiogenic growth factor expression in perivascular adipose tissue of patients with coronary artery disease. 2019, 8: 1000.","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1182\/blood-2010-02-267427","article-title":"Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis","volume":"117","author":"S Nakao","year":"2011","unstructured":"S Nakao. Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis. 2011, 117: 1081-1090.","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","article-title":"VEGFs and receptors involved in angiogenesis versus lymphangiogenesis","volume":"21","author":"M Lohela","year":"2009","unstructured":"M Lohela. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. 2009, 21: 154-165.","journal-title":"Curr Opin Cell Biol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/CM9.0000000000003407","article-title":"DDX24 promotes lymphangiogenesis and lymph node metastasis via AGRN production in cervical squamous cell carcinoma","volume":"138","author":"B Wang","year":"2025","unstructured":"B Wang. DDX24 promotes lymphangiogenesis and lymph node metastasis via AGRN production in cervical squamous cell carcinoma. 2025, 138: 361-363.","journal-title":"Chin Med J (Engl)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"177245","DOI":"10.1016\/j.ejphar.2024.177245","article-title":"Dihydrotanshinone I improves cardiac function by promoting lymphangiogenesis after myocardial ischemia-reperfusion injury","volume":"989","author":"YC Wang","year":"2025","unstructured":"YC Wang. Dihydrotanshinone I improves cardiac function by promoting lymphangiogenesis after myocardial ischemia-reperfusion injury. 2025, 989: 177245.","journal-title":"Eur J Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41419-019-2181-1","article-title":"Paclitaxel induces lymphatic endothelial cells autophagy to promote metastasis","volume":"10","author":"A Zamora","year":"2019","unstructured":"A Zamora. Paclitaxel induces lymphatic endothelial cells autophagy to promote metastasis. 2019, 10: 956.","journal-title":"Cell Death Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/cvr\/cvp141","article-title":"Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells","volume":"83","author":"JL Mart\u00edn-Ventura","year":"2009","unstructured":"JL Mart\u00edn-Ventura. Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells. 2009, 83: 586-594.","journal-title":"Cardiovasc Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s10528-023-10421-w","article-title":"Increased Expression of CD74 in Atherosclerosis Associated with Inflammatory Responses of Endothelial Cells and Macrophages","volume":"62","author":"K Ke","year":"2024","unstructured":"K Ke. Increased Expression of CD74 in Atherosclerosis Associated with Inflammatory Responses of Endothelial Cells and Macrophages. 2024, 62: 294-310.","journal-title":"Biochem Genet"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/metabo12010054","article-title":"CD74 in apoptotic macrophages is associated with inflammation, plaque progression and clinical manifestations in human atherosclerotic lesions","volume":"12","author":"W Li","year":"2022","unstructured":"W Li. CD74 in apoptotic macrophages is associated with inflammation, plaque progression and clinical manifestations in human atherosclerotic lesions. 2022, 12: 54.","journal-title":"Metabolites"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"106086","DOI":"10.1016\/j.phrs.2022.106086","article-title":"CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis","volume":"176","author":"L Chen","year":"2022","unstructured":"L Chen. CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis. 2022, 176: 106086.","journal-title":"Pharmacol Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1049143","DOI":"10.3389\/fcvm.2022.1049143","article-title":"The role of CD74 in cardiovascular disease","volume":"9","author":"QL Li","year":"2023","unstructured":"QL Li. The role of CD74 in cardiovascular disease. 2023, 9: 1049143.","journal-title":"Front Cardiovasc Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1450737","DOI":"10.3389\/fcvm.2024.1450737","article-title":"Immune cell-mediated features of atherosclerosis","volume":"11","author":"T Liu","year":"2024","unstructured":"T Liu. Immune cell-mediated features of atherosclerosis. 2024, 11: 1450737.","journal-title":"Front Cardiovasc Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.humimm.2023.06.002","article-title":"Role of inflammation and immune response in atherosclerosis: Mechanisms, modulations, and therapeutic targets","volume":"84","author":"F Liu","year":"2023","unstructured":"F Liu. Role of inflammation and immune response in atherosclerosis: Mechanisms, modulations, and therapeutic targets. 2023, 84: 439-449.","journal-title":"Hum Immunol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"100043","DOI":"10.1016\/j.engmed.2024.100043","article-title":"Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment","volume":"1","author":"ZY Wang","year":"2024","unstructured":"ZY Wang. Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment. 2024, 1: 100043.","journal-title":"EngMedicine"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41419-022-04552-y","article-title":"Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma","volume":"13","author":"Y Fukuda","year":"2022","unstructured":"Y Fukuda. Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma. 2022, 13: 117.","journal-title":"Cell Death Dis"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:36:33Z","timestamp":1789461393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2026.07.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2026.07.001","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}